{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:03:41Z","timestamp":1777971821191,"version":"3.51.4"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T00:00:00Z","timestamp":1204761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>CD20 is an important therapeutic target in chronic lymphocytic leukaemia (CLL). In order to examine the relationship between CD20 expression and cytogenetic abnormalities, we correlated the fluorescent <jats:italic>in\u2010situ<\/jats:italic> hybridization (FISH) genetic subtype of 510 treatment\u2010na\u00efve patients with CD20 expression as measured by quantitative flow cytometry. Patients were classified using the Dohner hierarchial classification. The median numbers of CD20 antigen sites by FISH subtypes were: 17p\u2010 (<jats:italic>n<\/jats:italic>\u2003=\u200326), 9341 per cell; 11q\u2010 (<jats:italic>n<\/jats:italic>\u2003=\u200342), 5886 per cell; +12 (<jats:italic>n<\/jats:italic>\u2003=\u200393), 23\u2003603 per cell; negative FISH (<jats:italic>n<\/jats:italic>\u2003=\u2003153), 8828 per cell; and 13q\u2010 (<jats:italic>n<\/jats:italic>\u2003=\u2003196), 10\u2003781 per cell. Compared to cases with negative FISH, 11q\u2010 cases had significantly lower CD20 expression (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7001), and +12 cases had significantly higher CD20 expression (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001). The significance of trisomy 12 and high CD20 expression was maintained after multivariate analysis accounting for other disease characteristics. Fifty\u2010nine patients received the combination of rituximab and granulocyte\u2010macrophage colony\u2010stimulating factor as frontline therapy; responses were observed in 13 of 14 (93%) patients with +12, in two of four (50%) patients with 11q\u2010, and in 30 of 41 (73%) patients with negative FISH, 13q\u2010 or 17p\u2010 CLL. Leukemic CD20 expression differed significantly between FISH subtypes. Patients with trisomy 12 CLL showed strong leukemic cell CD20 expression and had a high rate of response to rituximab\u2010based therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07012.x","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T19:50:51Z","timestamp":1204833051000},"page":"36-40","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in\u2010situ<\/i> hybridization in 510 patients"],"prefix":"10.1111","volume":"141","author":[{"given":"Constantine S.","family":"Tam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joselle","family":"Otero\u2010Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne V.","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Wierda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,6]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830400404"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.6.1424.1424"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109099325"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"214a","DOI":"10.1182\/blood.V106.11.721.721","article-title":"Rituximab plus GM\u2010CSF for patients with chronic lymphocytic leukemia","volume":"106","author":"Ferrajoli A.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/105.4.458"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.51.5.364"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.09.027"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1309\/438N-E0FH-A5PR-XCAC"},{"key":"e_1_2_5_12_1","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290703"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.051"},{"key":"e_1_2_5_15_1","first-page":"457","article-title":"Yttrium\u201090\u2010labeled anti\u2010CD20 monoclonal antibody therapy of recurrent B\u2010cell lymphoma","volume":"2","author":"Knox S.J.","year":"1996","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1639"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400819"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.584.584"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","article-title":"Characterization of a human B lymphocyte\u2010specific antigen","volume":"125","author":"Stashenko P.","year":"1980","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00661.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90276-3"},{"key":"e_1_2_5_23_1","first-page":"918","article-title":"Rituximab reduces the number of peripheral blood B\u2010cells in vitro mainly by effector cell\u2010mediated mechanisms","volume":"87","author":"Voso M.T.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049702"},{"key":"e_1_2_5_25_1","first-page":"511","volume-title":"CD20 Workshop Panel Report","author":"Zhou L.J.","year":"1995"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07012.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07012.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:45:08Z","timestamp":1697409908000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07012.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07012.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07012.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,6]]},"assertion":[{"value":"2008-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}